APA

Thondawada M., Wadhwani A. D., S Palanisamy D., Rathore H. S., Gupta R. C., Chintamaneni P. K., Samanta M. K., Dubala A., Varma S., Krishnamurthy P. T. & Gowthamarajan K. (20180919). An effective treatment approach of DPP-IV inhibitor encapsulated polymeric nanoparticles conjugated with anti-CD-4 mAb for type 1 diabetes. : Drug development and industrial pharmacy.

Chicago

Thondawada Mahesh, Wadhwani Ashish Devidas, S Palanisamy Dhanabal, Rathore Hanumant Singh, Gupta Ramesh C, Chintamaneni Pavan Kumar, Samanta Malay K, Dubala Anil, Varma Sameer, Krishnamurthy Praveen T and Gowthamarajan Kuppusamy. 20180919. An effective treatment approach of DPP-IV inhibitor encapsulated polymeric nanoparticles conjugated with anti-CD-4 mAb for type 1 diabetes. : Drug development and industrial pharmacy.

Harvard

Thondawada M., Wadhwani A. D., S Palanisamy D., Rathore H. S., Gupta R. C., Chintamaneni P. K., Samanta M. K., Dubala A., Varma S., Krishnamurthy P. T. and Gowthamarajan K. (20180919). An effective treatment approach of DPP-IV inhibitor encapsulated polymeric nanoparticles conjugated with anti-CD-4 mAb for type 1 diabetes. : Drug development and industrial pharmacy.

MLA

Thondawada Mahesh, Wadhwani Ashish Devidas, S Palanisamy Dhanabal, Rathore Hanumant Singh, Gupta Ramesh C, Chintamaneni Pavan Kumar, Samanta Malay K, Dubala Anil, Varma Sameer, Krishnamurthy Praveen T and Gowthamarajan Kuppusamy. An effective treatment approach of DPP-IV inhibitor encapsulated polymeric nanoparticles conjugated with anti-CD-4 mAb for type 1 diabetes. : Drug development and industrial pharmacy. 20180919.